| Schedule (route) | Endpoint | Vehicle | Dose | Treated/Control (%) | Observations |
|---|---|---|---|---|---|
| Q01DX001 (ip) | median survival time | alkali diluted with saline | 100.0 mg/kg/injection | 102.0 | Antitumor endpoint evaluated on day 30; 10/10 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | alkali diluted with saline | 100.0 mg/kg/injection | 96.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | alkali diluted with saline | 125.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 45; 05/10 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | alkali diluted with saline | 125.0 mg/kg/injection | 97.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | alkali diluted with saline | 150.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 04/10 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | alkali diluted with saline | 150.0 mg/kg/injection | 96.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | alkali diluted with saline | 175.0 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX001 (ip) | median survival time | alkali diluted with saline | 200.0 mg/kg/injection | 92.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | alkali diluted with saline | 10.0 mg/kg/injection | 106.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | alkali diluted with saline | 20.0 mg/kg/injection | 107.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | alkali diluted with saline | 40.0 mg/kg/injection | 112.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | alkali diluted with saline | 80.0 mg/kg/injection | 112.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | median survival time | alkali diluted with saline | 160.0 mg/kg/injection | 125.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | mean survival time | alkali diluted with water | 10.0 mg/kg/injection | 94.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | mean survival time | alkali diluted with water | 20.0 mg/kg/injection | 95.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | mean survival time | alkali diluted with water | 20.0 mg/kg/injection | 98.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | alkali diluted with water | 40.0 mg/kg/injection | 101.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | mean survival time | alkali diluted with water | 40.0 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | alkali diluted with water | 80.0 mg/kg/injection | 101.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | mean survival time | alkali diluted with water | 80.0 mg/kg/injection | 104.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX005 (ip) | mean survival time | alkali diluted with water | 160.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX005 (ip) | mean survival time | alkali diluted with water | 160.0 mg/kg/injection | 107.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline with Tween-80 | 25.0 mg/kg/injection | 104.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline with Tween-80 | 50.0 mg/kg/injection | 90.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline with Tween-80 | 100.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 05/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline with Tween-80 | 200.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 03/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | saline with Tween-80 | 400.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 03/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | alkali diluted with saline | 40.0 mg/kg/injection | 103.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | alkali diluted with saline | 40.0 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | alkali diluted with saline | 40.0 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 45; 07/07 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | alkali diluted with saline | 40.0 mg/kg/injection | 96.0 | Antitumor endpoint evaluated on day 45; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | alkali diluted with saline | 40.0 mg/kg/injection | 99.0 | Antitumor endpoint evaluated on day 30; 10/10 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | alkali diluted with saline | 40.0 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 30; 10/10 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | alkali diluted with saline | 50.0 mg/kg/injection | 105.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | alkali diluted with saline | 50.0 mg/kg/injection | 99.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | alkali diluted with saline | 50.0 mg/kg/injection | 98.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | alkali diluted with saline | 50.0 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 30; 10/10 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | alkali diluted with saline | 50.0 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 30; 10/10 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | alkali diluted with saline | 50.0 mg/kg/injection | 98.0 | Antitumor endpoint evaluated on day 45; 06/06 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | alkali diluted with saline | 50.0 mg/kg/injection | 96.0 | Antitumor endpoint evaluated on day 45; 07/07 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | alkali diluted with saline | 60.0 mg/kg/injection | 105.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | alkali diluted with saline | 60.0 mg/kg/injection | 102.0 | Antitumor endpoint evaluated on day 30; 10/10 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | alkali diluted with saline | 60.0 mg/kg/injection | 91.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX009 (ip) | median survival time | alkali diluted with saline | 70.0 mg/kg/injection | 101.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 9.38 mg/kg/injection | 101.0 | Antitumor endpoint evaluated on day 30; 08/08 animals surviving on day 5 |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 18.8 mg/kg/injection | 103.0 | Antitumor endpoint evaluated on day 30; 08/08 animals surviving on day 5 |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 37.5 mg/kg/injection | 110.0 | Antitumor endpoint evaluated on day 30; 08/08 animals surviving on day 5 |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 40.0 mg/kg/injection | 94.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 40.0 mg/kg/injection | 96.0 | Antitumor endpoint evaluated on day 60; 09/10 animals surviving on day 5 |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 40.0 mg/kg/injection | 95.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 50.0 mg/kg/injection | 94.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 50.0 mg/kg/injection | 96.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 60.0 mg/kg/injection | 88.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 75.0 mg/kg/injection | 110.0 | Antitumor endpoint evaluated on day 30; 08/08 animals surviving on day 5 |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 80.0 mg/kg/injection | 93.0 | Antitumor endpoint evaluated on day 45; 10/10 animals surviving on day 5 |
| Q01DX009 (ip) | mean survival time | alkali diluted with saline | 150.0 mg/kg/injection | 93.0 | Antitumor endpoint evaluated on day 30; 08/08 animals surviving on day 5 |